Rifabutin absorption in humans: relative bioavailability and food effect. 1992

P K Narang, and R C Lewis, and J R Bianchine
Department of Pharmacokinetics/Dynamics, Medical Research Center, Adria Laboratories, Columbus, OH 43216-6529.

The relative bioavailability of the capsule dose form (150 mg) and the effect of high-fat food were assessed in a randomized, three-way crossover trial of rifabutin in 12 healthy male volunteers. Each subject received a single 150 mg dose as a solution (treatment A, fasted) or a capsule with food (treatment B) and without food (treatment C), with a 2-week washout period. Serial plasma and urine samples were obtained for 168 and 48 hours, respectively, and rifabutin and its active metabolite, 25-O-deacetyl-rifabutin, quantitated by a validated HPLC procedure. The mean +/- SD maximum concentration for rifabutin in plasma was 238 +/- 65, 156 +/- 52, and 188 +/- 50 ng/ml, time to reach peak concentration was 2.5 +/- 0.4, 5.4 +/- 1.6, and 3.0 +/- 1.1 hours, and the area under the plasma concentration-time curve from zero to infinity [AUC(0-infinity)] was 2989 +/- 726, 2640 +/- 891, and 2516 +/- 601 ng.hr/ml for the solution and the capsule during the fed and fasted states, respectively. Percentage of dose excreted in the urine as unchanged rifabutin was 11.0% +/- 2.4%, 11.4% +/- 4.9%, and 9.1% +/- 2.1% for treatments A, B, and C, respectively. The corresponding AUC(0-infinity) values for the equiactive metabolite 25-O-deacetyl-rifabutin, were 400 +/- 184, 361 +/- 187, and 298 +/- 102 ng.hr/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P K Narang, and R C Lewis, and J R Bianchine
February 2006, European journal of nutrition,
P K Narang, and R C Lewis, and J R Bianchine
September 1978, Journal of pharmaceutical sciences,
P K Narang, and R C Lewis, and J R Bianchine
January 1989, Biopharmaceutics & drug disposition,
P K Narang, and R C Lewis, and J R Bianchine
July 1993, Journal of clinical pharmacology,
P K Narang, and R C Lewis, and J R Bianchine
March 2006, The American journal of clinical nutrition,
P K Narang, and R C Lewis, and J R Bianchine
March 1996, Journal of clinical pharmacology,
P K Narang, and R C Lewis, and J R Bianchine
January 1996, European journal of drug metabolism and pharmacokinetics,
P K Narang, and R C Lewis, and J R Bianchine
July 1992, Biopharmaceutics & drug disposition,
P K Narang, and R C Lewis, and J R Bianchine
January 1984, International journal of clinical pharmacology, therapy, and toxicology,
P K Narang, and R C Lewis, and J R Bianchine
October 1990, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!